Linked Life Data

8779198

Source:http://linkedlifedata.com/resource/pubmed/id/8779198

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1996-9-17
pubmed:abstractText
In the first half of the decade of the 1990s, we in the United States have seen the emergence and escalation of substantial antimicrobial resistance in medically important gram-positive cocci. The incidence of methicillin resistance of Staphylococcus aureus continues to increase (now 18%), resulting in many more isolates that are multiply resistant; all S aureus isolates are still susceptible to vancomycin. Enterococci, particularly Enterococcus faecium, have increasingly developed resistance to penicillin, gentamicin, streptomycin, and vancomycin (the last plasmid-mediated). More than a fourth of Streptococcus pneumoniae strains are now resistant to penicillin, and these strains tend to be multiply resistant, including to cephalosporins and macrolides.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0093-0415
pubmed:author
pubmed:issnType
Print
pubmed:volume
164
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
28-32
pubmed:dateRevised
2010-9-13
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Emerging resistance in clinically important gram-positive cocci.
pubmed:affiliation
MRL Pharmaceutical Services, Franklin, TN 37064, USA.
pubmed:publicationType
Journal Article, Review